TDAC
Translational Development Acquisition Corp.NASDAQFinancial Services$10.56-0.19%ClosedMarket Cap: $231.3M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
36.36
PEG
0.00
P/B
-27.95
P/S
0.00
EV/EBITDA
-245.82
DCF Value
—
FCF Yield
2.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
5.0%
ROA
3.5%
ROIC
-0.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $-553.3K | $1.6M | $-0.15 |
| FY 2025 | $0.00 | $6.4M | $0.37 |
| Q3 2025 | $137.7K | $1.7M | $0.08 |
| Q2 2025 | $191.8K | $1.6M | $0.07 |
Trading Activity
Insider Trades
View AllJarratt Christopher Kennethdirector:
SellMon Jan 06
Keith Curtis Tdirector:
SellFri Dec 20
TDAC Partners LLC10 percent owner
SellFri Dec 20
Reddy E Premkumardirector:
SellFri Dec 20
Kestenbaum Matthewdirector:
SellFri Dec 20
Company Info
Sector
Financial Services
Industry
—
Country
US
Exchange
NASDAQ
Beta
-0.01
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.